Capricor Therapeutics

1 follower

‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Biotechnology

Headquarters

Beverly Hills, United States

Employees

11-50

Links

Org chart

Linda Marbán

Chief Executive Officer

Linda Marbán

Collapse

Aj Bergmann

Chief Financial Officer

Kristi A. H. Elliott

Chief Science Officer

Mark Awadalla

Vice President Clinical Research & Development Operations

Yushi Feng

VP of Regulatory Affairs

Jonathan Tayco

Vice President Of Program Management, Operations And Quality

Joe Z.

Senior IP Counsel

Teams

+24

Research and Development

27 members

Leadership Team

3 members

Finance and Accounting

3 members

Similar companies

Immunome

2 followers

Amgen

208 followers

Miami Foundation

2 followers

Elicio Therapeutics

1 follower

Nunzio Marc DeSantis Architects

1 follower

Artiva Biotherapeutics

1 follower

Lucid Management and Capital Partners LP

1 follower

Thermo Fisher Scientific

160 followers

Merkle

63 followers

Publicis Sapient

47 followers

Roivant Sciences

56 followers

Explore companies